-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diabetes is a chronic disease that affects more than 460 million people worldwide
.
It is estimated that there are more than 113.
The journal Cell Stem Cell published an article titled “ Cell Stem Cell Cell Stem Cell Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes " research paper
In " the Cell Reports Medicine on the" journal published in " the Cell Reports Medicine the Cell Reports Medicine Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects Implanted with StemCell-derived pancreatic endoderm cells in AN encapsulation Device Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects The study "implanted with stemcell-derived pancreatic endoderm cells in an encapsulation device " further explained that 63% of PEC-01 cells were implanted and insulin expression observed 3-12 months after implantation in the body
End
org /10.
1016/j.
stem.
2021.
[1] https://doi.
[2] https://doi.
org/10.
1016/j.
xcrm.
2021.
100466 https://doi.
org/10.
1016/j.
xcrm.
2021.
100466 Leave a message here
.
It is estimated that there are more than 113.
The journal Cell Stem Cell published an article titled “ Cell Stem Cell Cell Stem Cell Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes " research paper
In " the Cell Reports Medicine on the" journal published in " the Cell Reports Medicine the Cell Reports Medicine Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects Implanted with StemCell-derived pancreatic endoderm cells in AN encapsulation Device Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects The study "implanted with stemcell-derived pancreatic endoderm cells in an encapsulation device " further explained that 63% of PEC-01 cells were implanted and insulin expression observed 3-12 months after implantation in the body
End
Reference materials:
Reference materials:[1] https://doi.
org /10.
1016/j.
stem.
2021.
[1] https://doi.
[2] https://doi.
org/10.
1016/j.
xcrm.
2021.
100466 https://doi.
org/10.
1016/j.
xcrm.
2021.
100466 Leave a message here